Authors:
OSTERMAIER R
VONESSEN R
ROTH M
OEL W
GRUBE E
MAURER W
TEBBE U
ERBEL R
BROM J
WEIDINGER G
Citation: R. Ostermaier et al., EFFECTS OF OCTREOTIDE TREATMENT AFTER CORONARY ANGIOPLASTY - NO REDUCTION OF RESTENOSIS OR CLINICAL EVENTS, Circulation, 94(8), 1996, pp. 528-528
Authors:
MAHRLE G
SCHULZE HJ
BRAUTIGAM M
MISCHER P
SCHOPF R
JUNG EG
WEIDINGER G
FARBER L
ALTMEYER P
AUBOCK J
BAUMANN S
FIERLBECK G
HAPPLE R
HAUSTEIN UF
KNOPF B
LUGER TA
MEYER J
RAINER F
RUZICKA T
SCHOPF EJ
WASSILEW SW
ZAUN HO
Citation: G. Mahrle et al., ANTIINFLAMMATORY EFFICACY OF LOW-DOSE CYCLOSPORINE-A IN PSORIATIC-ARTHRITIS - A PROSPECTIVE MULTICENTER STUDY, British journal of dermatology, 135(5), 1996, pp. 752-757
Authors:
BRAUTIGAM M
NOLTING S
SCHOPF RE
WEIDINGER G
Citation: M. Brautigam et al., RANDOMIZED DOUBLE-BLIND COMPARISON OF TERBINAFINE AND ITRACONAZOLE FOR TREATMENT OF TOENAIL TINEA INFECTION, BMJ. British medical journal, 311(7010), 1995, pp. 919-922
Authors:
SCHATZ F
BRAUTIGAM M
DOBROWOLSKI E
EFFENDY I
HABERL H
MENSING H
WEIDINGER G
STUTZ A
Citation: F. Schatz et al., NAIL INCORPORATION KINETICS OF TERBINAFINE IN ONYCHOMYCOSIS PATIENTS, Clinical and experimental dermatology, 20(5), 1995, pp. 377-383
Authors:
HANEKE E
TAUSCH I
BRAUTIGAM M
WEIDINGER G
WELZEL D
Citation: E. Haneke et al., SHORT-DURATION TREATMENT OF FINGERNAIL DERMATOPHYTOSIS - A RANDOMIZED, DOUBLE-BLIND-STUDY WITH TERBINAFINE AND GRISEOFULVIN, Journal of the American Academy of Dermatology, 32(1), 1995, pp. 72-77
Authors:
MAHRLE G
SCHULZE HJ
FARBER L
WEIDINGER G
STEIGLEDER GK",HUMS,PRIFERT,ALBRECHT,BORCHERS,KREYSEL,LINDENBLATT,VOGEL,KOSCHINSKI,HAGEDORN,SATTLER,GORING,PANZNER,SCHUBERT,LINDNER,TAUBE,FIEDLER,PETZOLDT,TILGEN,BAHMER,WACKER,KNOPF,BARTA,ROTH,HAUSTEIN,BIELLA,WOLFF,QUAST,SCHLENZKA,ARENSMEIER,PESCHLOW,KNOP,SCHOPF,JUNG,BAYERL,KOLDE,WESTPHAL,WURDEL,NITZSCHNER,ETTELT
Citation: G. Mahrle et al., LOW-DOSE SHORT-TERM CYCLOSPORINE VERSUS ETRETINATE IN PSORIASIS - IMPROVEMENT OF SKIN, NAIL, AND JOINT INVOLVEMENT, Journal of the American Academy of Dermatology, 32(1), 1995, pp. 78-88
Citation: G. Weidinger, PHARMACOKINETIC AND PHARMACODYNAMIC PROPERTIES AND THERAPEUTIC USE OFBUNAZOSIN IN HYPERTENSION - A REVIEW, Arzneimittel-Forschung, 45-2(11), 1995, pp. 1166-1171
Authors:
HOFMANN H
BRAUTIGAM M
WEIDINGER G
ZAUN H
ALTMEYER P
ANTAL I
BERNS W
BORELLI S
DIETERLE R
FRIEDERICH HC
GLOWANIA HJ
GOOS M
HANEKE E
HOLZMANN H
JUNG EG
KNOP J
KREYSEL HW
MARGHESCU S
MENSING H
PAUL E
PETRES J
REINEL D
ROSINUS A
SCHOPF R
TRONNIER H
Citation: H. Hofmann et al., TREATMENT OF TOENAIL ONYCHOMYCOSIS - A RANDOMIZED, DOUBLE-BLIND-STUDYWITH TERBINAFINE AND GRISEOFULVIN, Archives of dermatology, 131(8), 1995, pp. 919-922
Authors:
EICHSTADT HW
ESKOTTER H
HOFFMANN I
AMTHAUER HW
WEIDINGER G
Citation: Hw. Eichstadt et al., IMPROVEMENT OF MYOCARDIAL PERFUSION BY SHORT-TERM FLUVASTATIN THERAPYIN CORONARY-ARTERY DISEASE, The American journal of cardiology, 76(2), 1995, pp. 122-125
Authors:
SCHMIEDER RE
WEIHPRECHT H
GATZKA C
WEIDINGER G
SCHOBEL H
Citation: Re. Schmieder et al., IS ENDOTHELIUM FUNCTION ALTERED IN HUMAN ESSENTIAL-HYPERTENSION, Journal of the American Society of Nephrology, 5(3), 1994, pp. 567-567
Citation: Eg. Jung et al., SYSTEMIC TREATMENT OF SKIN CANDIDOSIS - A RANDOMIZED COMPARISON OF TERBINAFINE AND KETOCONAZOLE, Mycoses, 37(9-10), 1994, pp. 361-365
Authors:
HAUFE CC
SERAKOWSKI B
GRASS P
JANSA U
WEIDINGER G
STEIN G
Citation: Cc. Haufe et al., PHARMACOKINETICS OF THE ACE-INHIBITOR SPI RAPRIL IN PATIENTS WITH CHRONIC-RENAL-FAILURE, Nieren- und Hochdruckkrankheiten, 23(5), 1994, pp. 213-216
Authors:
LOHMANN FW
WEIDINGER G
SCHALLER K
SCHARDT F
WELZEL D
Citation: Fw. Lohmann et al., ANTIHYPERTENSIVE TREATMENT WITH ALPHA(1)- ADRENOCEPTOR ANTAGONISTS - A COMPARISON BETWEEN BUNAZOSIN AND DOXAZOSIN, Nieren- und Hochdruckkrankheiten, 23(2), 1994, pp. 63-69
Citation: S. Nolting et al., TERBINAFINE IN ONYCHOMYCOSIS WITH INVOLVEMENT BY NON-DERMATOPHYTIC FUNGI, British journal of dermatology, 130, 1994, pp. 16-21
Citation: R. Kirsten et G. Weidinger, THERAPY OF ESSENTIAL-HYPERTENSION WITH THE ALPHA(1)-ANTAGONIST BUNAZOSIN RETARD - MULTICENTER DOUBLE-BLIND PLACEBO-CONTROLLED-STUDY, Arzneimittel-Forschung, 44-1(1), 1994, pp. 13-16
Authors:
GRETEN H
BEIL FU
SCHNEIDER J
WEISWEILER P
ARMSTRONG VW
KELLER C
KLOR HU
VONHODENBERG E
WEIDINGER G
ESKOTTER H
FARBER L
ASSMANN G
Citation: H. Greten et al., TREATMENT OF PRIMARY HYPERCHOLESTEROLEMIA - FLUVASTATIN VERSUS BEZAFIBRATE, The American journal of medicine, 96, 1994, pp. 190000055-190000063
Citation: H. Rieckert et al., ORTHOSTATIC HYPOTENSION DURING ANTIHYPERTENSIVE TREATMENT WITH BUNAZOSIN AND PRAZOSIN, Drug investigation, 5(6), 1993, pp. 327-333
Authors:
EICHSTADT H
WEIDINGER G
STORK T
DANNE O
CORDES M
WELZEL D
Citation: H. Eichstadt et al., EXERCISE TOLERANCE AND HEMODYNAMICS IN PA TIENTS WITH ARTERIAL-HYPERTENSION UNDER THERAPY WITH BUNAZOSIN RETARD, Herz, Kreislauf, 25(11), 1993, pp. 356-360